Compare TIL & ORIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TIL | ORIQ |
|---|---|---|
| Founded | 2018 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 87.6M |
| IPO Year | 2021 | 2025 |
| Metric | TIL | ORIQ |
|---|---|---|
| Price | $7.13 | $10.11 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $125.00 | N/A |
| AVG Volume (30 Days) | ★ 251.8K | 18.5K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.67 | $9.98 |
| 52 Week High | $42.79 | $10.20 |
| Indicator | TIL | ORIQ |
|---|---|---|
| Relative Strength Index (RSI) | 30.97 | N/A |
| Support Level | $5.67 | N/A |
| Resistance Level | $7.42 | N/A |
| Average True Range (ATR) | 0.73 | 0.00 |
| MACD | -0.33 | 0.00 |
| Stochastic Oscillator | 19.65 | 0.00 |
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Origin Investment Corp I is a blank check company.